Last $0.11 USD
Change Today +0.0009 / 0.81%
Volume 6.4M
CBIS On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

cannabis science inc (CBIS) Snapshot

Open
$0.11
Previous Close
$0.11
Day High
$0.11
Day Low
$0.11
52 Week High
02/6/14 - $0.30
52 Week Low
12/23/13 - $0.03
Market Cap
85.2M
Average Volume 10 Days
16.8M
EPS TTM
--
Shares Outstanding
761.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CANNABIS SCIENCE INC (CBIS)

cannabis science inc (CBIS) Related Bloomberg News

View More Bloomberg News

cannabis science inc (CBIS) Related Businessweek News

No Related Businessweek News Found

cannabis science inc (CBIS) Details

Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance. The company has a license agreement with Apothecary Genetics Investments LLC. to produce various brand formulations for California medical cannabis market. Cannabis Science, Inc. is based in Colorado Springs, Colorado. Cannabis Science, Inc. operates as a subsidiary of Weedmaps Media, Inc.

2 Employees
Last Reported Date: 04/23/13

cannabis science inc (CBIS) Top Compensated Officers

President and Director
Total Annual Compensation: $60.0K
Co-Founder, Chief Operating Officer, General ...
Total Annual Compensation: --
Compensation as of Fiscal Year 2012.

cannabis science inc (CBIS) Key Developments

Cannabis Science, Inc. announced delayed annual 10-K filing

On 03/31/2014, Cannabis Science, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Cannabis Science, Inc. Signs Partnership Agreement with Michigan Green Technologies, LLC

Cannabis Science, Inc. announced its new partnership with Michigan Green Technologies, LLC that has a broad focus on the reform and proper implementation of state approved cannabis and commercial hemp programs with comprehensive seed to sale process to include cultivation; studies; medical testing; manufacturing; a taxation model; commercial and consumer distribution; education; and clinical research.

Cannabis Science, Inc. Announces Plans for Observational Research Study in 2014

Cannabis Science, Inc. announced plans for international observational studies and research in 2014. Plans announced by the company to launch an observational clinical research study in 2014 will focus on patient driven use of cannabis and cannabis based products and the clinical outcomes of such use for a variety of medical conditions. The company will seek additional funding partners as well as academic and clinical collaborators for this project. The company has been continuously conducting research into on cannabis and cannabinoids and in 2013 has also filed an application of a cannabinoid based patent and believes there is an enormous potential for the extension of its portfolio and filing of further patents. The direction of Cannabis Science is supported by Dr. Sanjay Gupta's reversing his original position on cannabis from believing that it was harmful to supporting the use of medical cannabis.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBIS:US $0.11 USD +0.0009

CBIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Medical Marijuana Inc $0.22 USD +0.037
Nuvilex Inc $0.35 USD +0.074
View Industry Companies
 

Industry Analysis

CBIS

Industry Average

Valuation CBIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,893.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2,259.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANNABIS SCIENCE INC, please visit www.cannabisscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.